|
|
Photodynamic
Therapy -
|
Levulan Kerastick
|
Cost |
| Levulan
Photodynamic Therapy - Acne Treatment
Acne treatments using Levulan Photodynamic Therapy (PDT)
is the
most recent advance in acne therapy. Perfect Skin laser Center was
one of the first clinics in Arizona to offer this revolutionary acne
treatment. We have been getting
excellent results treating men and women of all ages from all over
Phoenix, Scottsdale, Chandler area. Photodynamic
acne therapy involves the application of Levulan ( 5-aminolevulinic
acid), a photosensitizing agent, which is then activated with blue-light.
This results in significant improvement in moderate to severe cystic
acne.
Levulan
Photodynamic Therapy - Skin Rejuvenatuion
Photorejuvenation
using intense pulsed light (IPL) is now the gold standard of non-ablative
skin treatments. The most recent advance in photorejuvenation is
photodynamic therapy (PDT) combined with IPL, known as photodynamic
skin rejuvenation. Photodynamic skin rejuvenation involves the application
of Levulan, a photosensitizing agent, which is then activated with
IPL and blue-light. This results in significant improvement in precancerous
conditions such as AKs, actinically damaged skin, sun damaged skin,
moderate to severe cystic acne and potentially superficial skin cancers.
DUSA Announces Stiefel's Receipt of Pricing Approval of Levulan PDT in Brazil (CCNMatthews via Yahoo! Finance)
WILMINGTON, MASSACHUSETTS-- - DUSA Pharmaceuticals, Inc. , received notice on March 5, 2008 that Stiefel Laboratories, Inc., DUSA's marketing partner for Latin America, has now received final pricing approval for Levulan Kerastick for Photodynamic Therapy for the treatment of actinic keratoses in Brazil by the Regulatory Chamber of Medicines . DUSA Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Corporate Highlights and Financial Results (Marketwire via Yahoo! Finance)
DUSA Pharmaceuticals, Inc.®, a dermatology company that is developing and marketing Levulan® photodynamic therapy and other products targeting patients with common skin conditions, reported today its corporate highlights and financial results for the fourth quarter and full year ended December 31, 2007. DUSA Pharmaceuticals Reports Third Quarter 2007 Financial Results and Corporate Highlights (Marketwire via Yahoo! Finance)
DUSA Pharmaceuticals, Inc.®, a dermatology company that is developing and marketing Levulan® photodynamic therapy and other products targeting patients with common skin conditions, reported today its corporate highlights and financial results for the third quarter ended September 30, 2007. DUSA Announces Stiefel's Receipt of Pricing Approval of Levulan PDT in Brazil (Marketwire via Yahoo! Finance)
DUSA Pharmaceuticals, Inc.®, received notice on March 5, 2008 that Stiefel Laboratories, Inc., DUSA's marketing partner for Latin America, has now received final pricing approval for Levulan® Kerastick® for Photodynamic Therapy for the treatment of actinic keratoses in Brazil by the Regulatory Chamber of Medicines. |
Photodynamic
Therapy |
|
 |
Conventional type I IPL
photorejuvenation for rosacea, telangiectasia: 550 nm filter, 2.4
msec - 2.4 msec double pulse, 10 msec delay, 24-34 J/cm2. Photos
courtesy of Mark S. Nestor, M.D., Ph.D. |
 |
 |
| Photodynamic skin rejuvenation
(type III) for chronic actinic damage, actinic keratosis: 550 nm
filter, 2.4 msec - 2.4 msec double pulse, 10 msec delay, 24 J/cm2
-34 J/cm2. First three IPL treatments included light microdermabrasion
followed by a 30-minute application of ALA. Photos courtesy of
Mark S. Nestor, M.D., Ph.D. |
 |
 |
Extensive actinic keratoses and photodamage treated with 1-hour
application of ALA followed by IPL at conventional photorejuvenation
parameters of 2.4 msec - 4.0 msec double pulse, 10 msec delay, 32
J/cm2. Photos courtesy of Mitchel P. Goldman, M.D. |
|
 |
| Before and after treatment
of squamous cell carcinoma in situ treated with application of
ALA for 1 hour followed by IPL at conventional photorejuvenation
parameters. Photos courtesy of Mitchel P. Goldman, M.D. |
|
 |
| Photodynamic skin rejuvenation
for severe cystic acne with three treatments, which included light
microdermabrasion followed by ALA application for 30 minutes to
60 minutes , followed by IPL and/or pulsed dye laser (2.6 J/cm2).
Photos courtesy of Mark S. Nestor, M.D., Ph.D. |
| |
|
| Conventional type 1 IPL
photorejuvenation for pores and texture: 560 nm filter, 4. 0 msec
- 6.0 msec double pulse, 10 msec delay, 22 J/cm2 - 30 J/cm2. Photos
courtesy of Mark S. Nestor, M.D., Ph.D. |
| |
|
